← All diseases Rare and hereditary disorders

Epidermolysis bullosa

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchMost rigorous evidence only (52)Treatment guideline (7)Meta-analysis (4)Systematic review (18)Phase 3 Study (15)Randomized trial (8)Clinical trial (147)Review article (153)Early study (phase 1 or 2) (20)Single patient description (248)Laboratory or animal research (18)Commentary or editorial (88)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1209)

• Defining patient-centered research priorities in pediatric dermatology. (2023/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Opening Pandora's box: abnormal genetic carrier screening and need for lifetime follow-up. (2023/03/01) ♡
• Rare diseases of ectoderm: Translating discovery to therapy. (2023/03/01) ♡
• Transition of care in patients with epidermolysis bullosa: A survey study. (2023/03/01) ♡
• Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. (2023/03/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gastrostomy tube feeding in epidermolysis bullosa: A multi-center assessment of caregiver satisfaction. (2023/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. (2023/02/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Dystrophic Epidermolysis Bullosa in a Preschooler in a Middle Eastern Country. (2023/02/09) ♡
• Novel compound heterozygous mutations in the PLEC gene in a neonate with epidermolysis bullosa simplex with pyloric atresia. (2023/02/01) ♡
• Epidemiology of inherited epidermolysis bullosa in Germany. (2023/02/01) ♡
• Genotype and phenotype correlations in 441 patients with epidermolysis bullosa from China. (2023/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom. (2023/02/01) ♡
• Risk factors and sequelae of epidermolysis bullosa acquisita: A propensity-matched global study in 1,344 patients. (2023/01/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epidermolysis Bullosa with Pyloric Atresia. (2023/01/26) ♡
• Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France. (2023/01/01) ♡
• Validation and Repeatability of the Epidermolysis Bullosa Eye Disease Index in Dystrophic Epidermolysis Bullosa. (2023/01/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Rituximab in Subepidermal Blistering Diseases. (2023/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Recessive dystrophic epidermolysis bullosa (RDEB): Oral manifestation and management rules in oral surgery: A case report. (2023/01/01) ♡
• COL7A1 Homozygous Arg2471Ter Mutation Leads to the Severe Phenotype of Autosomal Recessive Dystrophic Epidermolysis Bullosa in the Fetus. (2023/01/01) ♡
• Prevalence of delayed puberty and low bone density in patients with epidermolysis bullosa: Insight from a large single center's experience. (2023/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients (2023-09-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy of Topical TolaSure Targeting Aggregated Mutant Keratin in Severe Epidermolysis Bullosa Simplex (2023-09-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa (2023-08-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial (2023-08-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex (2023-08-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa (2023-08-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (2023-07-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa (2023-07-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene (2023-03-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB (2023-02-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa (2023-02-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (2023-02-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients (2023-01-31) ♡
• Mutational analysis of epidermolysis bullosa in Taiwan by whole-exome sequencing complemented by RNA sequencing: a series of 77 patients. (2022/12/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Skin-Derived ABCB5(+) Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine. (2022/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Epidermolysis Bullosa Acquisita: A Rare Autoimmune Blistering Disease in Children. (2022/12/20) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Recessive Dystrophic Epidermolysis Bullosa: Rare Bilateral External Auditory Canal Stenosis and Surgical Treatment. (2022/12/16) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa. (2022/12/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa. (2022/12/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Topical Gene Therapy for Epidermolysis Bullosa. (2022/12/15) ♡
• Correction: Hand surgery and hand therapy clinical practice guideline for epidermolysis bullosa. (2022/12/15) ♡
• Familial Epidermolysis Bullosa Pruriginosa. (2022/12/14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The C4EB study-Transvamix (10% THC / 5% CBD) to treat chronic pain in epidermolysis bullosa: A protocol for an explorative randomized, placebo controlled, and double blind intervention crossover study. (2022/12/12) ♡
• KRT5 missense variant in a Cardigan Welsh Corgi with epidermolysis bullosa simplex. (2022/12/01) ♡
• Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series. (2022/12/01) ♡
• New options to manage epidermolysis bullosa. (2022/12/01) ♡
• Esophageal Manifestations of Dermatological Diseases, Diagnosis and Management. (2022/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Rare variants of pemphigoid diseases]. (2022/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases. (2022/11/30) ♡
• School inclusion of children and adolescents with epidermolysis bullosa: The mothers' perspective. (2022/11/28) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.